Differential blockade of early and late components of acoustic startle following intrathecal infusion of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) ord,l-2-amino-5-phosphonovaleric acid (AP-5)

Add time:09/06/2019    Source:sciencedirect.com

The present study investigated the individual contributions of spinal cord N-methyl-d-aspartate (NMDA) and non-NMDA receptors to the acoustic startle reflex in rats. The first experiment measured whole body acoustic startle before and after intrathecal infusion of various doses of either the NMDA receptor antagonist,d,l-2-amino-5-phosphonovaleric acid (AP-5), or the non-NMDA antagonist, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX). Both compounds depressed startle in a dose-dependent fashion with similar potencies. A second experiment measured startle electromyographically (EMG) in the quadriceps femoris muscle complex in the hindlimbs during auditory stimulation to characterize the effects of these two compounds on the early (∼ 8ms) or late (∼ 15ms) EMG components of the startle response. CNQX preferentially blocked the early EMG component of startle, whereas AP-5 preferentially blocked the late component. These results suggest that the acoustic startle reflex involves an early EMG component mediated by spinal non-NMDA receptors, and a late EMG component mediated by spinal NMDA receptors.

We also recommend Trading Suppliers and Manufacturers of 5-NITROQUINOXALINE (cas 18514-76-6). Pls Click Website Link as below: cas 18514-76-6 suppliers

Prev:Comparison of FT Raman spectra of some 5-NITROQUINOXALINE (cas 18514-76-6)s and their electropolymers
Next:Local infusion of the (±)-α-amino-3-hydroxy-5-methylisoxazole-4-propionate/kainate receptor antagonist 6-cyano-7-nitroquinoxaline-2,3-dione does not block d1 dopamine receptor-mediated increases in immediate early gene expression in the dopamine-depleted striatum)